ERK3 Is Involved in Regulating Cardiac Fibroblast Function
P. Sahadevan, D. Dingar, S. A. Nawaito…·B. G. Allen
This study shows ERK3 regulates cardiac fibroblast function by affecting collagen production and motility in response to TGF-β and TAC.
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
P. Sahadevan, D. Dingar, S. A. Nawaito…·B. G. Allen
This study shows ERK3 regulates cardiac fibroblast function by affecting collagen production and motility in response to TGF-β and TAC.
S. S. Johnson, D. Liu, J. T. Ewald…·M. Fath
This study shows auranofin inhibits TrxR in SCLC and NET cells, sensitizes them to sorafenib, and extends survival in xenograft models without toxicity.
J. Trepanier, S. A. Nawaito, P. Sahadevan…·B. G. Allen
This study shows MK2 deficiency reduces mortality and alters cytokine levels during the inflammatory phase after myocardial infarction in mice.
A. Rauckhorst, G. V. Martinez, G. M. Andrade…·D. Zepeda-Orozco
The paper shows that reducing mitochondrial pyruvate carrier activity in kidney tubular cells protects against acute kidney injury by enhancing redox defenses and survival.
M. Ruiz, M. Khairallah, D. Dingar…·B. G. Allen
This study examines the cardiac phenotype of MK2-deficient mice, finding altered autonomic regulation, increased metabolic gene expression, reduced mitochondrial Ca2+-sensitivity, and delayed hypertrophic remodeling in response to pressure overload.
H. Nassour, T. A. Hoang, R. D. Martin…·D. Chatenet
The paper synthesizes and characterizes pepducins from the urotensin II receptor, showing they act as biased allosteric modulators with specific signaling effects.
P. Sahadevan, S. A. Nawaito, J. Trepanier…·B. G. Allen
This study investigates MK5 expression, localization, and phosphorylation in cardiac myofibroblasts and myocytes, finding that p38/{beta} mediates T182-MK5 phosphorylation and activation.
G. Coulis, Y. Shi, D. P. Labbe…·B. Boivin
This study shows that PTP1B inactivation disrupts miR-208b-Argonaute 2 interaction, leading to increased THRAP1 expression and thyroid hormone-induced cardiac hypertrophy.